Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General Aniline Works was a prominent American chemical and pharmaceutical manufacturer that played a significant role in the early 20th-century dye and drug industries. Originally established as a joint venture involving the German conglomerate I.G. Farben, the company focused on the production of aniline dyes, intermediates, and synthetic organic chemicals. During World War II, the company was seized by the U.S. government under the Trading with the Enemy Act and eventually became part of the General Aniline & Film Corporation (GAF). Its legacy is tied to the development of early synthetic medications and the foundation of the modern specialty chemical industry in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gen Aniline Works.